4th Congress on Innovation in Drug Delivery
Site-Specific Drug Delivery
25-28 September, 2016
Antibes-Juan-les-Pins, France


The conference center offers the possibility to rent a boot. For more information, please contact apgi.asso@u-psud.fr or Download the Sponsorship-Exhibition Package

 Logo_Evonik_26_Feb_2016.jpg Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Evonik is active in over 100 countries and focuses on the key megatrends health, nutrition, resource efficiency and globalization. With its Health Care Business Line, Evonik offers an experienced team who understands the challenges of drug delivery. The unique portfolio includes market leading pharmaceutical excipients, smart drug delivery technologies, formulation development services, and GMP manufacturing for oral and parenteral drugs. Visit the site for Resomer and  Eudragit.
 malvern Malvern Instruments characterizes particles ranging from powders to proteins. The new laser particle size analyzers measure size, charge, shape and molecular weight. In 2014 Malvern acquired MicroCal and sells and installs ITC (Isothermal Titration Calorimetry) and DSC (Differential Scanning Calorimetry). Malvern launched in January 2015 a new system called PEAQ for GPC/SEC which follows a new SEC MALS detector in 2014. The company is also heavily involved in the Biosciences with 5 new instruments: Viscosizer using the Taylor dispersion, Morphologi G3 ID combining image analysis and Raman spectroscopy, Archimedes characterizing protein aggregates, Helix identifying chemical bonds with DLS combined with Raman and Nanosight to count nanoparticles in complex environments.

PCAS, a fine chemical company, operates 7 world-class chemical plants in Europe and North America, including 4 FDA inspected sites. PCAS offers services for process development and manufacturing from k-labs to ton scale of Active Ingredients, intermediates and Pharma excipients as exclusive synthesis. PCAS also offers a catalogue of APIs and excipients on routine production. 

PCAS’ excipients portfolio includes 40 biodegradable polymers for sustained release of small molecule and selected injectable peptides, allowing customers to optimize control release kinetics of final drug products. PLA- and PLGA- (Expansorb® line) based formulations have already been approved by the FDA and the EMA and several drug products are already on the market; with many others drug products ongoing clinical development. 

Last News: PCAS announced a global agreement with MilliporeSigma (Merck KGaA division) to become the exclusive and global distributor of its controlled release' excipients portfolio (Expansorb® line).

Contact: karine.salim@pcas.com - www.pcas.com


About Sirius Analytical

Sirius Analytical is a market leader in the fields of measurement of physicochemical properties, biorelevant solubility and dissolution and in vitro modelling of in vivo behaviour of formulated biological drugs. Our expertise areas include the delivery of oral, inhaled, injected and transdermal drugs.


Sirius also offers analytical and consultancy services to help our customers solve all kinds of small and large molecule formulation challenges.






Online user: 1